CELL & GENE THERAPY INSIGHTS

Cellular immuno-oncology – overcoming manufacturing and development obstacles to commercial success

Guest Editor:
Fritz Fiesser, Director, C&GT Engineering and Informatics at GlaxoSmithKline
Fritz Fiesser
Director, C&GT Engineering and Informatics at GlaxoSmithKline
June 2021